Medication-assisted therapy for opioid addiction

Betty Tai ^a,*, Andrew J. Saxon ^b,c, Walter Ling ^d

a Center for Clinical Trials Network, National Institute on Drug Abuse, Bethesda, MD, USA
b Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System, Seattle,
WA, USA
c Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA
d Integrated Substance Abuse Programs, David Geffen School of Medicine, University of California, Los Angeles, CA, USA

The “Medication-Assisted Therapy for Opioid Addiction” session was chaired by Dr Betty Tai and had three presenters. The presenters (and their topics) were: Dr Andrew J. Saxon (methadone and buprenorphine for treatment of opioid addiction and human immunodeficiency virus risk reduction); Dr Walter Ling (opioid antagonist treatment for opioid addiction); and Dr Betty Tai (chronic care model for substance use disorder).

Keywords:Buprenorphine, Chronic care model, Methadone, Opioid addiction